Reviva Pharmaceuticals Holdings annual shareholders’ equity
2019
2019
2020
2020
2021
2022
2023
2024
2025
Reviva Pharmaceuticals Holdings Shareholders’ Equity Growth & History (RVPH)
Reviva Pharmaceuticals Holdings's shareholders’ equity was $8.6M for fiscal 2025.
View full Reviva Pharmaceuticals Holdings company overviewReviva Pharmaceuticals Holdings annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.6M | $7.8M | +964.23% |
| 2024 | 2024-12-31 | $812,572 | −$4.9M | −85.79% |
| 2023 | 2023-12-31 | $5.7M | −$2.7M | −31.87% |
| 2022 | 2022-12-31 | $8.4M | −$20.3M | −70.74% |
| 2021 | 2021-12-31 | $28.7M | $23.2M | +424.84% |
| 2020 · Dec 31 | 2020-12-31 | $5.5M | $12.3M | — |
| 2020 · Feb 29 | 2020-02-29 | $5.0M | −$1 | −0.00% |
| 2019 · Dec 31 | 2019-12-31 | −$6.8M | — | — |
| 2019 · Feb 28 | 2019-02-28 | $5.0M | — | — |
Reviva Pharmaceuticals Holdings quarterly shareholders’ equity
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.2M | $15.7M | — |
| Q1 2026 | 2026-03-31 | $17.4M | $21.9M | — |
| Q4 2025 | 2025-12-31 | $8.6M | $7.8M | +964.23% |
| Q3 2025 | 2025-09-30 | $4.5M | $14.5M | — |
| Q2 2025 | 2025-06-30 | −$459,147 | $5.6M | — |
| Q1 2025 | 2025-03-31 | −$4.5M | −$3.1M | — |
| Q4 2024 | 2024-12-31 | $812,572 | −$4.9M | −85.79% |
| Q3 2024 | 2024-09-30 | −$10.0M | $2.8M | — |
| Q2 2024 | 2024-06-30 | −$6.0M | −$4.2M | — |
| Q1 2024 | 2024-03-31 | −$1.3M | −$3.0M | — |
| Q4 2023 | 2023-12-31 | $5.7M | −$2.7M | −31.87% |
| Q3 2023 | 2023-09-30 | −$12.8M | −$33.2M | — |
| Q2 2023 | 2023-06-30 | −$1.8M | −$17.9M | — |
| Q1 2023 | 2023-03-31 | $1.6M | −$19.7M | −92.45% |
| Q4 2022 | 2022-12-31 | $8.4M | −$20.3M | −70.74% |
| Q3 2022 | 2022-09-30 | $20.4M | −$11.9M | −36.91% |
| Q2 2022 | 2022-06-30 | $16.1M | −$18.5M | −53.48% |
| Q1 2022 | 2022-03-31 | $21.4M | $16.8M | +372.96% |
| Q4 2021 | 2021-12-31 | $28.7M | $23.2M | +424.84% |
| Q3 2021 · Sep 30 | 2021-09-30 | $32.3M | — | — |
| Q2 2021 · Jun 30 | 2021-06-30 | $34.5M | — | — |
| Q1 2021 · Mar 31 | 2021-03-31 | $4.5M | — | — |
| Q4 2020 · Dec 31 | 2020-12-31 | $5.5M | $12.3M | — |
| Q3 2021 · Nov 30 | 2020-11-30 | $5.0M | $4 | +0.00% |
| Q2 2021 · Aug 31 | 2020-08-31 | $5.0M | −$3 | −0.00% |
| Q1 2021 · May 31 | 2020-05-31 | $5.0M | −$7 | −0.00% |
| Q4 2020 · Feb 29 | 2020-02-29 | $5.0M | −$1 | −0.00% |
| Q4 2019 · Dec 31 | 2019-12-31 | −$6.8M | — | — |
| Q3 2020 | 2019-11-30 | $5.0M | −$2 | −0.00% |
| Q2 2020 | 2019-08-31 | $5.0M | −$4 | −0.00% |
| Q1 2020 | 2019-05-31 | $5.0M | — | — |
| Q4 2019 · Feb 28 | 2019-02-28 | $5.0M | — | — |
| Q3 2019 | 2018-11-30 | $5.0M | — | — |
| Q2 2019 | 2018-08-31 | $5.0M | — | — |
Reviva Pharmaceuticals Holdings shareholders’ equity trends
Over the last five fiscal years, Reviva Pharmaceuticals Holdings's shareholders’ equity increased from $5.5M to $8.6M, a change of $3.2M. The latest reported quarter, Q2 2026, shows $15.2M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Reviva Pharmaceuticals Holdings source filings ↗